Close Menu

NEW YORK – Stock prices for many diagnostics companies took a downturn after two months of minimal change for the 360Dx Index.

The index dropped nearly 4 percent month over month in September, after declining a fraction of 1 percent in August. Of the 29 companies in the index, 16 firms' stocks were down and 13 companies' share prices increased.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.